QIAGEN

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.

About QGEN

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.

CEO

Thierry L. Bernard

CEOThierry L. Bernard

Employees

5,654

Employees5,654

Headquarters

Venlo, Limburg

HeadquartersVenlo, Limburg

Founded

1996

Founded1996

Employees

5,654

Employees5,654

QGEN Key Statistics

Market cap

6.87B

Market cap6.87B

Price-Earnings ratio

16.89

Price-Earnings ratio16.89

Dividend yield

0.80%

Dividend yield0.80%

Average volume

2.44M

Average volume2.44M

High today

$33.77

High today$33.77

Low today

$33.01

Low today$33.01

Open price

$33.06

Open price$33.06

Volume

1.85M

Volume1.85M

52 Week high

$57.82

52 Week high$57.82

52 Week low

$32.53

52 Week low$32.53

Stock Snapshot

With a market cap of 6.87B, QIAGEN(QGEN) trades at $33.34. The stock has a price-to-earnings ratio of 16.89 and currently yields dividends of 80.5%.

On 2026-05-14, QIAGEN(QGEN) stock moved within a range of $33.01 to $33.77. With shares now at $33.34, the stock is trading +1.0% above its intraday low and -1.3% below the session's peak.

Trading activity shows a volume of 1.85M, compared to an average daily volume of 2.44M.

The stock's 52-week range extends from a low of $32.53 to a high of $57.82.

QGEN News

Simply Wall St 13h

Does Qiagen's Bigger Dividend and Governance Shift Signal a New Capital Allocation Playbook?

In May 2026, QIAGEN N.V. proposed a 40% increase in its annual cash dividend to US$0.35 per share for approval at the June 24, 2026 Annual General Meeting, whil...

TipRanks 1d

QIAGEN Board Member Makes $2 Million Open-Market Share Purchase

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Simply Wall St 5d

Assessing Qiagen Valuation After A Sharp Multi‑Month Share Price Pullback

Advertisement Context on Qiagen’s recent share performance Qiagen (QGEN) has drawn attention after a run of weaker returns, with the stock down about 3% over...

Analyst ratings

59%

of 22 ratings

Buy

40.9%

Hold

59.1%

Sell

More QGEN News

TipRanks 6d

Qiagen holds profit targets as Q1 2026 results expose QuantiFERON drag

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 6d

Qiagen Files U.S. GAAP Quarterly Report for First Quarter 2026

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 7d

Qiagen price target lowered to $40 from $46 at TD Cowen

TD Cowen analyst Dan Brennan lowered the firm’s price target on Qiagen (QGEN) to $40 from $46 and keeps a Hold rating on the shares. The firm updated its model...

People also own

Based on the portfolios of people who own QGEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.